Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel

Afzal Hussain,1 Mohammad A Altamimi,1 Sultan Alshehri,1 Syed Sarim Imam,1 Faiyaz Shakeel,1 Sandeep Kumar Singh2 1Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; 2Department of Pharmaceutical Sciences, Birla Institute of Technology, Ranchi, Jha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hussain A, Altamimi MA, Alshehri S, Imam SS, Shakeel F, Singh SK
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/850c35b658d94647a1c61c3c0f493e42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:850c35b658d94647a1c61c3c0f493e42
record_format dspace
spelling oai:doaj.org-article:850c35b658d94647a1c61c3c0f493e422021-12-02T03:22:48ZNovel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel1178-2013https://doaj.org/article/850c35b658d94647a1c61c3c0f493e422020-02-01T00:00:00Zhttps://www.dovepress.com/novel-approach-for-transdermal-delivery-of-rifampicin-to-induce-synerg-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Afzal Hussain,1 Mohammad A Altamimi,1 Sultan Alshehri,1 Syed Sarim Imam,1 Faiyaz Shakeel,1 Sandeep Kumar Singh2 1Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; 2Department of Pharmaceutical Sciences, Birla Institute of Technology, Ranchi, Jharkhand, IndiaCorrespondence: Afzal HussainDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Kingdom of Saudi ArabiaTel +966 5 64591584Email afzal.pharma@gmail.comPurpose: This study demonstrated improved transdermal delivery of rifampicin-loaded cationic nanoemulsion gel to treat systemic and cutaneous tuberculosis using capmul, labrasol, and acconon, which exert anti-Mycobacterium activities. This approach enhanced drug permeation across the skin, increased therapeutic efficacy, and reduced dose-related side effects.Methods: Design Expert® was used to optimize formulations (Smix ratio and capmul as independent factors), which were prepared using a slow spontaneous titration method. The optimized nanoemulsion was incorporated into carbopol gel to allow for topical application and comparative assessments. Nanoemulsions and gels were evaluated for size, size distribution, shape, zeta potential, percent spread, viscosity, in vitro hemolysis, in vitro release, and ex vivo skin permeation and deposition. A mechanistic evaluation was performed using scanning electron microscopy. Furthermore, in vivo pharmacokinetic and irritation studies were performed.Results: The optimized cationic nanoemulsion (OCNE-1) was characterized by small particle size (≤ 100 nm), had optimal viscosity, percent spread, zeta potential, and percent drug release, and was hemocompatible. The OCNE-1T gel exhibited higher permeation flux (51.32 ± 0.5 μg/cm2 hr), permeation coefficient (2.566 ± 0.08 cm/hr), drug deposition (994.404 μg/cm2), and enhancement ratio (7.16) than those of the OCNE-1 nanoemulsion or drug solution. Scanning electron microscopy was used to characterize the mechanism of enhanced permeation. An In vivo study showed that the Cmax and area under the curve following transdermal application were 4.34- and 4.74-fold higher than those following oral administration.Conclusion: Transdermal delivery of rifampicin could be a promising alternative to conventional approaches to treat systemic and local tuberculosis, and other bacterial infections.Keywords: systemic and cutaneous tuberculosis, nanoemulsion gel, transdermal delivery, permeation parameters, bioavailabilityHussain AAltamimi MAAlshehri SImam SSShakeel FSingh SKDove Medical Pressarticlesystemic and cutaneous tuberculosisnanoemulsion geltransdermal deliverypermeation parametersbioavailabilityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1073-1094 (2020)
institution DOAJ
collection DOAJ
language EN
topic systemic and cutaneous tuberculosis
nanoemulsion gel
transdermal delivery
permeation parameters
bioavailability
Medicine (General)
R5-920
spellingShingle systemic and cutaneous tuberculosis
nanoemulsion gel
transdermal delivery
permeation parameters
bioavailability
Medicine (General)
R5-920
Hussain A
Altamimi MA
Alshehri S
Imam SS
Shakeel F
Singh SK
Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
description Afzal Hussain,1 Mohammad A Altamimi,1 Sultan Alshehri,1 Syed Sarim Imam,1 Faiyaz Shakeel,1 Sandeep Kumar Singh2 1Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia; 2Department of Pharmaceutical Sciences, Birla Institute of Technology, Ranchi, Jharkhand, IndiaCorrespondence: Afzal HussainDepartment of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Kingdom of Saudi ArabiaTel +966 5 64591584Email afzal.pharma@gmail.comPurpose: This study demonstrated improved transdermal delivery of rifampicin-loaded cationic nanoemulsion gel to treat systemic and cutaneous tuberculosis using capmul, labrasol, and acconon, which exert anti-Mycobacterium activities. This approach enhanced drug permeation across the skin, increased therapeutic efficacy, and reduced dose-related side effects.Methods: Design Expert® was used to optimize formulations (Smix ratio and capmul as independent factors), which were prepared using a slow spontaneous titration method. The optimized nanoemulsion was incorporated into carbopol gel to allow for topical application and comparative assessments. Nanoemulsions and gels were evaluated for size, size distribution, shape, zeta potential, percent spread, viscosity, in vitro hemolysis, in vitro release, and ex vivo skin permeation and deposition. A mechanistic evaluation was performed using scanning electron microscopy. Furthermore, in vivo pharmacokinetic and irritation studies were performed.Results: The optimized cationic nanoemulsion (OCNE-1) was characterized by small particle size (≤ 100 nm), had optimal viscosity, percent spread, zeta potential, and percent drug release, and was hemocompatible. The OCNE-1T gel exhibited higher permeation flux (51.32 ± 0.5 μg/cm2 hr), permeation coefficient (2.566 ± 0.08 cm/hr), drug deposition (994.404 μg/cm2), and enhancement ratio (7.16) than those of the OCNE-1 nanoemulsion or drug solution. Scanning electron microscopy was used to characterize the mechanism of enhanced permeation. An In vivo study showed that the Cmax and area under the curve following transdermal application were 4.34- and 4.74-fold higher than those following oral administration.Conclusion: Transdermal delivery of rifampicin could be a promising alternative to conventional approaches to treat systemic and local tuberculosis, and other bacterial infections.Keywords: systemic and cutaneous tuberculosis, nanoemulsion gel, transdermal delivery, permeation parameters, bioavailability
format article
author Hussain A
Altamimi MA
Alshehri S
Imam SS
Shakeel F
Singh SK
author_facet Hussain A
Altamimi MA
Alshehri S
Imam SS
Shakeel F
Singh SK
author_sort Hussain A
title Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
title_short Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
title_full Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
title_fullStr Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
title_full_unstemmed Novel Approach for Transdermal Delivery of Rifampicin to Induce Synergistic Antimycobacterial Effects Against Cutaneous and Systemic Tuberculosis Using a Cationic Nanoemulsion Gel
title_sort novel approach for transdermal delivery of rifampicin to induce synergistic antimycobacterial effects against cutaneous and systemic tuberculosis using a cationic nanoemulsion gel
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/850c35b658d94647a1c61c3c0f493e42
work_keys_str_mv AT hussaina novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
AT altamimima novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
AT alshehris novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
AT imamss novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
AT shakeelf novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
AT singhsk novelapproachfortransdermaldeliveryofrifampicintoinducesynergisticantimycobacterialeffectsagainstcutaneousandsystemictuberculosisusingacationicnanoemulsiongel
_version_ 1718401805033930752